Related Experiment Video
Updated: Dec 3, 2025
06:39
Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
313
Sleep in Hospitalized Children With Cancer: A Cross-Sectional Study
Chani Traube1,2, Lynne Rosenberg3, Francesca Thau3
1Departments of Pediatrics, chr9008@med.cornell.edu.
Hospital Pediatrics
|October 30, 2020
Summary
Most hospitalized children with cancer experience inadequate sleep. Hospital factors like noise, alarms, child worries, and benzodiazepines contribute to poor sleep, highlighting areas for potential intervention.
Area of Science:
- Pediatric Oncology
- Sleep Medicine
- Clinical Research
Background:
- Hospitalized children with cancer often face sleep disruption.
- In-hospital sleep disturbances may negatively impact patient outcomes.
Purpose of the Study:
- To characterize sleep quality and quantity in hospitalized pediatric cancer patients.
- To evaluate the association between subjective and objective sleep measures.
- To identify hospital-associated risk factors for poor sleep.
Main Methods:
- Cross-sectional study involving 56 children (0-18 years) on a pediatric oncology ward.
- Parental sleep questionnaires and actigraphy were used to assess sleep.
- Data included demographics, clinical information, and hospital-associated factors.
Main Results:
- 66% of participants reported inadequate sleep.
- Actigraphy showed a median total sleep time of 477 minutes.
- Noise, alarms, child's worries, and benzodiazepine use were linked to inadequate sleep.
Conclusions:
- Inadequate sleep is prevalent in hospitalized children with cancer.
- Subjective and objective sleep measures correlated well.
- Modifiable hospital factors present targets for sleep improvement interventions.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
132
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
132
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
151
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
151
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
124
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124